qinlock
deciphera pharmaceuticals (netherlands) b.v. - ripretinib - guzy stromal żołądkowo-jelitowe - Środki przeciwnowotworowe - qinlock is indicated for the treatment of adult patients with advanced gastrointestinal stromal tumour (gist) who have received prior treatment with three or more kinase inhibitors, including imatinib.
rennie extra 625 mg + 73,5 mg + 150 mg tabletki do żucia
bayer sp. z o.o. - calcii carbonas + magnesii subcarbonas ponderosus + acidum alginicum - tabletki do żucia - 625 mg + 73,5 mg + 150 mg
maalox 400 mg + 400 mg tabletki
opella healthcare poland sp. z o.o. - aluminii hydroxidum + magnesii hydricum - tabletki - 400 mg + 400 mg
maalox (35 mg + 40 mg)/ml zawiesina doustna
opella healthcare poland sp. z o.o. - aluminii hydroxidum + magnesii hydroxidum - zawiesina doustna - (35 mg + 40 mg)/ml
rosuvastatin ranbaxy 5 mg tabletki powlekane
ranbaxy (poland) sp. z o.o. - rosuvastatinum calicum - tabletki powlekane - 5 mg
rosuvastatin ranbaxy 10 mg tabletki powlekane
ranbaxy (poland) sp. z o.o. - rosuvastatinum calicum - tabletki powlekane - 10 mg
rosuvastatin ranbaxy 20 mg tabletki powlekane
ranbaxy (poland) sp. z o.o. - rosuvastatinum calicum - tabletki powlekane - 20 mg
rosuvastatin ranbaxy 40 mg tabletki powlekane
ranbaxy (poland) sp. z o.o. - rosuvastatinum calicum - tabletki powlekane - 40 mg
maalox (460 mg + 400 mg)/4,3 ml zawiesina doustna
opella healthcare poland sp. z o.o. - aluminii oxidum hydricum + magnesii hydroxidum - zawiesina doustna - (460 mg + 400 mg)/4,3 ml
aporoza 5 mg tabletki powlekane
apotex europe b.v. - rosuvastatinum calicum - tabletki powlekane - 5 mg